Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends
Report Scope:
This report aims to comprehensively study the market size of AML and treatments for a global market. Current and historical market revenues can be estimated based on treatment type, route of administration, end use, distribution channel and region.
Report Includes:
42 data tables and 57 additional tables
An overview of the global market for acute myeloid leukemia (AML) treatment
Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
Highlights of the market potential and characterization of AML market based on treatment type, route of administration type, end-users, distribution channel, region
Coverage of various risk factors associated with AML, such as exposure to radiation or chemicals, genetic disorders, and weakened immune system
Description of major treatment options for AML such as, chemotherapy, targeted therapy, and stem cell transplantation
Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
Detailed company profiles of major players in the market of the industry, including AbbVie, Daiichi Sankyo, GlaxoSmithKline PLC, Pfizer Inc. and Servier
Companies Mentioned
ABBVIE
AMGEN INC.
ASTELLAS PHARMA INC.
BAYER AG
BIOGEN
BRISTOL MYERS SQUIBB
DAIICHI SANKYO CO. LTD.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
MERCK & CO. INC.
NOVARTIS
PFIZER INC.
SANOFI
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Methodology Information Sources Primary Research Secondary Research Geographic Breakdown Chapter 2 Summary and Highlights Market Outlook This Report Highlights Chapter 3 Market Overview and Definitions Overview Acute Myeloid Leukemia The Global Regulatory Structure for AML Pricing and Reimbursement for AML Therapies/Drugs to Treat AML FLT3 Inhibitors IDH Inhibitors Apoptosis Stimulants DNA Methylation Inhibitors DNA Intercalators Angiogenesis Inhibitors DNA Synthesis Inhibitors Chapter 4 Market Dynamics Market Drivers Growing Elderly Population Increasing Incidence and Prevalence Advancements in Molecular Diagnostics Minimal Residual Disease (MRD) Monitoring Gene Expression Profiling Fusion Gene Detection Liquid Biopsies R&D Regulatory Environment Personalized Medicine Collaborative Efforts Patient Advocacy and Awareness Market Opportunity Strategic Initiative Market Restraints High Costs Limited Treatment Options Treatment-related Toxicity and Adverse Effects Regulatory and Reimbursement Challenges Chapter 5 Impact of COVID-19 Introduction COVID-19 Impact on AML Treatments Chapter 6 Market Breakdown by Region Market Overview and Discussion North America Europe Asia-Pacific Rest of the World Chapter 7 Market Breakdown by Treatment Type Market Overview and Discussion Targeted Therapy Anthracycline Drugs Other Chemotherapies Targeted Therapy Anthracycline Drugs Other Chemotherapies Chapter 8 Market Breakdown by Route of Administration Market Overview and Discussion Intravenous (IV) Administration Oral Administration Intravenous (IV) Administration Chapter 9 Market Breakdown by Product FLT3 Inhibitors Apoptosis Stimulants Angiogenesis Inhibitors DNA Methylation Inhibitors DNA Synthesis Inhibitors DNA Intercalators Chapter 10 ESG Development Introduction Environment Governance Chapter 11 Emerging Trends and Technologies Introduction Chapter 12 Competitive Landscape Overview Industry Scenario Company Shares Chapter 13 Patent Analysis Patent Analysis by Manufacturer Chapter 14 Pipeline Analysis Clinical Trail Scenario Chapter 15 M&A and Venture Funding Outlook Introduction Chapter 16 Company Profiles ABBVIE AMGEN INC. ASTELLAS PHARMA INC. BAYER AG BIOGEN BRISTOL MYERS SQUIBB DAIICHI SANKYO CO. LTD. GILEAD SCIENCES INC. GLAXOSMITHKLINE PLC MERCK & CO. INC. NOVARTIS PFIZER INC. SANOFI SERVIER LABORATORIES TEVA PHARMACEUTICAL INDUSTRIES LTD. Chapter 17 Appendix: Acronyms
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook